H1 FY26 Results Announcement
Filed with ASX · · 4 pages · English
• H1 FY26 total revenue of $3.9 million, up 3% on the previous corresponding period (PCP) • Revenue uplift in Gateway (5%), Marketplace (24%), New Zealand (54%) (PCP) • Positive EBITDA of $0.5 million • Costs on plan with reduction of headcount post Single Platform launch • Increased Gross Margin to 84% (up 2%) • Closing cash position of $3.2 million • Marketplace successfully launched and continu
PharmX Technologies Limited on 6ix
In the deck
Story so far
Earlier from PharmX Technologies
- Pharmx and Sigma enter multi-year strategic alliance
- Investor Presentation
- FY25 Results
- Appendix 4E & FY2025 Annual Report
- Reinstatement to Quotation
Later from PharmX Technologies
- H1 FY26 Investor Presentation
- Appendix 4E & FY26 Annual Report
- Announcement of FY26 Results
- FY26 Results Presentation
Follow PharmX Technologies into a list and get an email when it puts out news.
Follow PharmX Technologies